Medicine
Assessment and Management of Acute Upper Gastrointestinal Bleeding
Quick fact
Acute upper GI bleeding kills about 10% of patients who present with it. Rapid risk scoring—not just visual assessment—determines who needs urgent endoscopy and who can be safely watched.
Why this is interesting
You see a patient vomiting blood in the ER. In the minutes before the scope goes in, what decisions decide whether they live?
Read the full explanation
Understanding Assessment and Management of Acute Upper Gastrointestinal Bleeding
When a patient presents with acute upper GI bleeding, the first step is to assess for hemodynamic instability—looking for low blood pressure, fast heart rate, or signs of shock. The next is to stabilize the patient: secure IV access, give fluids or blood transfusions, and correct any coagulopathy. Then, use a validated risk score like the Glasgow-Blatchford score to stratify the patient. Low-risk patients might be managed as outpatients or with delayed endoscopy; high-risk patients need urgent endoscopy within 24 hours. During endoscopy, doctors identify the bleeding source—commonly a peptic ulcer—and apply direct treatment like injecting epinephrine, thermal coagulation, or clipping the vessel. Pharmacological therapy with proton pump inhibitors is started to raise gastric pH and promote clot stability, and in cases of variceal bleeding, octreotide and antibiotics are added. The mechanism is all about balancing the urgency of intervention with the need for hemodynamic resuscitation, because pushing too fast or too slow can be fatal.
A deeper explanation
The underlying principle is that acute GI bleeding leads to hypovolemia and reduced end-organ perfusion. The body compensates via sympathetic activation—vasoconstriction, tachycardia, and shunting of blood to vital organs. The initial assessment must rapidly identify the extent of blood loss—using clinical signs and lab tests like hemoglobin and lactate. Risk scores like the Glasgow-Blatchford and Rockall integrate clinical and endoscopic findings to predict mortality and rebleeding. The decision to perform endoscopy is based on these scores; high-risk patients (e.g., with hematemesis, shock, or high scores) need urgent endoscopy because early intervention can stop bleeding and reduce mortality. During endoscopy, the bleeding lesion is visualized, and hemostasis is achieved through techniques: injection of epinephrine to vasoconstrict and tamponade, thermal coagulation to cauterize the vessel, or mechanical clips to ligate. After achieving hemostasis, acid suppression is key because gastric acid can dissolve the blood clot that forms over the bleeding vessel, increasing the risk of rebleeding. The concept matters because timely and appropriate management reduces mortality from this emergency, which can otherwise be rapidly fatal—especially in patients with variceal bleeding due to portal hypertension, where vasoactive drugs like octreotide are essential to reduce portal pressure, and prophylactic antibiotics are given to prevent infections that worsen outcome.